| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Joseph B Mandeville, Christin Y M Sander, Bruce G Jenkins, Jacob M Hooker, Ciprian Catana, Wim Vanduffel, Nathaniel M Alpert, Bruce R Rosen, Marc D Normandi. A receptor-based model for dopamine-induced fMRI signal. NeuroImage. vol 75. 2013-11-26. PMID:23466936. |
this report describes a multi-receptor physiological model of the fmri temporal response and signal magnitude evoked by drugs that elevate synaptic dopamine in basal ganglia. |
2013-11-26 |
2023-08-12 |
human |
| Dimitri Ryczko, Swantje Grätsch, François Auclair, Catherine Dubé, Saskia Bergeron, Michael H Alpert, Jackson J Cone, Mitchell F Roitman, Simon Alford, Réjean Dubu. Forebrain dopamine neurons project down to a brainstem region controlling locomotion. Proceedings of the National Academy of Sciences of the United States of America. vol 110. issue 34. 2013-11-26. PMID:23918379. |
the contribution of dopamine (da) to locomotor control is traditionally attributed to ascending dopaminergic projections from the substantia nigra pars compacta and the ventral tegmental area to the basal ganglia, which in turn project down to the mesencephalic locomotor region (mlr), a brainstem region controlling locomotion in vertebrates. |
2013-11-26 |
2023-08-12 |
monkey |
| Jeff A Beeler, Giselle Petzinger, Michael W Jakowe. The Enemy within: Propagation of Aberrant Corticostriatal Learning to Cortical Function in Parkinson's Disease. Frontiers in neurology. vol 4. 2013-11-18. PMID:24062721. |
under dopamine denervation, corticostriatal plasticity is altered, resulting in aberrant learning that induces inappropriate basal ganglia filtering that impedes rather than optimizes cortical processing. |
2013-11-18 |
2023-08-12 |
human |
| D N Voronkov, R M Khudoerkov, E L Dovedov. [Changes in neuroglial interactions in the cerebral nigrostriatal structures in a model of dopamine system dysfunction]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 113. issue 7. 2013-11-12. PMID:23994921. |
it has been supposed that the activation of astroglia by reserpine in a dopamine hypofunction model is caused by the dysfunction of the corticostriatal glutamatergic system as a result of inhibition of the dopaminergic transmission in the basal nuclei. |
2013-11-12 |
2023-08-12 |
rat |
| Yuji Kitaichi, Takeshi Inoue, Nobuyuki Mitsui, Shin Nakagawa, Rie Kameyama, Yoshiyuki Hayashishita, Tohru Shiga, Ichiro Kusumi, Tsukasa Koyam. Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report. Neuropsychiatric disease and treatment. vol 9. 2013-11-08. PMID:24204150. |
[(18)f]-fluorodeoxyglucose positron emission tomography (fdg-pet) showed increased glucose metabolism in the bilateral basal ganglia after initiating selegiline treatment; blood dopamine levels were also increased after selegiline treatment. |
2013-11-08 |
2023-08-12 |
Not clear |
| Satoshi Fujita, Risako Kato, Yilong Cui, Masanori Terakado, Kurando Suga, Noriaki Koshikawa, Masayuki Kobayash. Apomorphine-induced modulation of neural activities in the ventrolateral striatum of rats. Synapse (New York, N.Y.). vol 67. issue 7. 2013-11-07. PMID:23401143. |
the dopaminergic system in the ventrolateral portion of the striatum (svl), part of the basal ganglia, regulates orofacial movements; bilateral co-stimulation of both dopamine d1 -like and d2 -like receptors elicits repetitive jaw movements in rats. |
2013-11-07 |
2023-08-12 |
rat |
| Caroline Fasano, Marie-Josée Bourque, Gabriel Lapointe, Damiana Leo, Dominic Thibault, Michael Haber, Christian Kortleven, Luc Desgroseillers, Keith K Murai, Louis-Éric Trudea. Dopamine facilitates dendritic spine formation by cultured striatal medium spiny neurons through both D1 and D2 dopamine receptors. Neuropharmacology. vol 67. 2013-11-04. PMID:23231809. |
these results represent a first step in the understanding of how dopamine neurons promote the structural plasticity of msns during the development of basal ganglia circuits. |
2013-11-04 |
2023-08-12 |
Not clear |
| Sylvia Navailles, Mélanie Lagière, Audrey Roumegous, Marina Polito, Méric B Boujema, Martine Cador, John Dunlop, Marie-Françoise Chesselet, Mark J Millan, Philippe De Deurwaerdèr. Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's disease. The international journal of neuropsychopharmacology. vol 16. issue 3. 2013-10-31. PMID:22717119. |
the differential sensitivity of their actions to depletion of dopamine suggests recruitment of different contrasting neural mechanisms in the basal ganglia. |
2013-10-31 |
2023-08-12 |
rat |
| Anna Costa, Michael Riedel, Oliver Pogarell, Frank Menzel-Zelnitschek, Markus Schwarz, Maximilian Reiser, Hans-Jürgen Möller, Katya Rubia, Thomas Meindl, Ulrich Ettinge. Methylphenidate effects on neural activity during response inhibition in healthy humans. Cerebral cortex (New York, N.Y. : 1991). vol 23. issue 5. 2013-09-30. PMID:22581848. |
methylphenidate (mph) is a catecholamine transporter blocker, with dopamine agonistic effects in the basal ganglia. |
2013-09-30 |
2023-08-12 |
human |
| Glen R Hanson, Amanda J Hoonakker, Christina M Robson, Lisa M McFadden, Paul S Frankel, Mario E Alburge. Response of neurotensin basal ganglia systems during extinction of methamphetamine self-administration in rat. The Journal of pharmacology and experimental therapeutics. vol 346. issue 2. 2013-09-25. PMID:23685547. |
thus, we investigated the response of central nervous system neurotensin (nt) systems to meth self-administration (sa) and their interaction with basal ganglia dopamine (da) pathways. |
2013-09-25 |
2023-08-12 |
rat |
| Martin Thirkettle, Thomas Walton, Ashvin Shah, Kevin Gurney, Peter Redgrave, Tom Staffor. The path to learning: action acquisition is impaired when visual reinforcement signals must first access cortex. Behavioural brain research. vol 243. 2013-08-28. PMID:23380676. |
short-latency dopamine (da) signalling in the basal ganglia has been proposed to support this crucial task. |
2013-08-28 |
2023-08-12 |
Not clear |
| P M Abedi, C Delaville, P De Deurwaerdère, W Benjelloun, A Benazzou. Intrapallidal administration of 6-hydroxydopamine mimics in large part the electrophysiological and behavioral consequences of major dopamine depletion in the rat. Neuroscience. vol 236. 2013-08-26. PMID:23376117. |
they support the assumption that in addition to its action in the striatum, dopamine mediates its regulatory function at various levels of the basal ganglia circuitry, including the gp. |
2013-08-26 |
2023-08-12 |
rat |
| Paolo Calabresi, Massimiliano Di Filippo, Antongiulio Gallina, Yingfei Wang, Jeannette N Stankowski, Barbara Picconi, Valina L Dawson, Ted M Dawso. New synaptic and molecular targets for neuroprotection in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. vol 28. issue 1. 2013-08-21. PMID:22927178. |
the defining anatomical feature of parkinson's disease (pd) is the degeneration of substantia nigra pars compacta (snc) neurons, resulting in striatal dopamine (da) deficiency and in the subsequent alteration of basal ganglia physiology. |
2013-08-21 |
2023-08-12 |
Not clear |
| Sang Baek Ryu, Eun Kyung Bae, Jinhyung Kim, Yong Sup Hwang, Changkyun Im, Jin Woo Chang, Hyung-Cheul Shin, Kyung Hwan Ki. Neuronal Responses in the Globus Pallidus during Subthalamic Nucleus Electrical Stimulation in Normal and Parkinson's Disease Model Rats. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology. vol 17. issue 4. 2013-08-15. PMID:23946689. |
because pd results from the degeneration of dopamine neurons that affect the basal ganglia (bg) network, investigation of neuronal responses of bg neurons during stn dbs can provide informative insights for the understanding of the mechanism of therapeutic effect. |
2013-08-15 |
2023-08-12 |
rat |
| In-Uk Song, Young-Do Kim, Hyun-Ji Cho, Sung-Woo Chung, Yong-An Chun. An FP-CIT PET comparison of the differences in dopaminergic neuronal loss between idiopathic Parkinson disease with dementia and without dementia. Alzheimer disease and associated disorders. vol 27. issue 1. 2013-08-12. PMID:22354157. |
previous studies have demonstrated a decreased density of dopamine transporters (dat) in basal ganglia in patients with idiopathic parkinson disease (ipd) using i-n-fluoropropyl-2b-carbomethoxy-3b-(4-iodophenyl) nortropane (fp-cit), and the reductions in striatal dat levels were inversely correlated with the severity of motor dysfunction in ipd. |
2013-08-12 |
2023-08-12 |
Not clear |
| Foteini Delis, Ada Mitsacos, Panagiotis Giompre. Lesion of the cerebellar paravermis increases dopamine D1 receptor levels in the contralateral striatum. Journal of chemical neuroanatomy. vol 47. 2013-08-09. PMID:23116569. |
we have previously shown that a complete, genetic, lack of purkinje cells induces an upregulation of dopamine d1 receptors (drd1) in the output of the basal ganglia, the substantia nigra pars reticulata. |
2013-08-09 |
2023-08-12 |
Not clear |
| Masaharu Hayash. [Anti-basal ganglia antibody]. Brain and nerve = Shinkei kenkyu no shinpo. vol 65. issue 4. 2013-08-07. PMID:23568985. |
recently, the relationship between abga and dopamine neurons in the basal ganglia has been examined, and autoantibodies against dopamine receptors were detected in the sera from patients with basal ganglia encephalitis. |
2013-08-07 |
2023-08-12 |
Not clear |
| Lorraine V Kalia, Jonathan M Brotchie, Susan H Fo. Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials. Movement disorders : official journal of the Movement Disorder Society. vol 28. issue 2. 2013-08-06. PMID:23225267. |
neurotransmitters other than dopamine are recognized as having modulatory roles within the basal ganglia and can influence the basal ganglia dopaminergic system to alter activity of the direct and indirect pathways. |
2013-08-06 |
2023-08-12 |
Not clear |
| Kenji Morita, Mieko Morishima, Katsuyuki Sakai, Yasuo Kawaguch. Dopaminergic control of motivation and reinforcement learning: a closed-circuit account for reward-oriented behavior. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 33. issue 20. 2013-08-02. PMID:23678129. |
these results indicate that the suggested roles of dopamine in motivational control and reinforcement learning can be understood in a unified manner through a notion that the indirect pathway of the basal ganglia represents the value of states/actions at a previous time point, an empirically driven key assumption of our model. |
2013-08-02 |
2023-08-12 |
Not clear |
| Khaled-Ezaheir Bennouar, Michelle A Uberti, Christophe Melon, Maria D Bacolod, Hermogenes N Jimenez, Manuel Cajina, Lydia Kerkerian-Le Goff, Darío Doller, Paolo Gubellin. Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia. Neuropharmacology. vol 66. 2013-07-02. PMID:22491024. |
group iii metabotropic glutamate (mglu) receptors are localized in presynaptic terminals within basal ganglia (bg) circuitry that become hyperactive due to dopamine depletion in parkinson's disease (pd). |
2013-07-02 |
2023-08-12 |
rat |